CutisPharma, Resolve collaborate to provide progesterone suppositories to infertility patients

McLEAN, Va. An organization that advocates on behalf of men and women with infertility will collaborate with a Massachusetts pharmaceutical company to provide pharmacy compounding kits used to create suppositories to treat the condition.

Resolve: The National Infertility Association announced a collaboration with Woburn, Mass.-based CutisPharma to introduce the company and its progesterone suppository compounding kits to Resolve constituents.

“We are pleased to partner with Resolve in increasing our product awareness among Resolve members, supporters and healthcare professionals,” CutisPharma CEO Indu Muni said. “As the leader in providing family building support and information to the public, Resolve is a trusted source.”

The company estimates that more than 1.5 million prescriptions are written every year for progesterone suppositories.